MedTrace Logo

An Efficacy Study of BCS Clearing the Oral Colonized Bacterium in Hospitalized Patients With COPD

NCT02269800 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2014-10-21

No results posted yet for this study

Summary

The purpose of study is to evaluate the efficacy and safety of Benzalkonium Chloride Solution clearing the oral colonized bacterium in hospitalized patients with COPD.

Conditions

Interventions

DRUG

Benzalkonium chloride solution

Tid, 7 days

DRUG

Normal saline

Tid, 7 days

Sponsors & Collaborators

  • Lustre Pharmaceutical Lab Co., Ltd

    lead INDUSTRY

Principal Investigators

  • Shiyue Li, Professor · The First Affiliated Hospital of Guangzhou Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2015-07-31
Completion
2015-07-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02269800 on ClinicalTrials.gov